Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Could TPL be involved

<could it benefit them, in any way, having this action delayed? > IMO NO.

Not even in their negotiations with Moore?

< strong NIRC response would put great pressure on them to deliver > IMO No. The opposite would be true. It would make it easier to deliver.

It should be easier but will they deliver fast enough....Exactly the reason why there will be great pressure on them.

<They could finance their efforts by sale pf stock in PTSC if it were to appreciate significantly.> I don't think TPL has that many shares and I think it would take quite a few shares to finance their efforts at current prices

I think old man Lecky said he alone had 2.5 mil shares. In a pinch they may have to resort to selling shares if we get some appreciation.

Share
New Message
Please login to post a reply